CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pharmacia & Upjohn Company LLC v. Apotex, Inc.

1:13-cv-02034

Overview

Case Number 1:13-cv-02034
Filing Date 2013-03-15
Status Terminated
Termination Date 2013-12-19
Court District Court, N.D. Illinois (ilnd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Pharmacia & Upjohn Company LLC Operating Company

Represented By

8 Attorneys Listed

Counter Claimant

Counter Defendant

Pfizer Asia-Pacific Pte. Ltd. Operating Company

Represented By

8 Attorneys Listed

Court & Judges

Court

District Court, N.D. Illinois (ilnd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5688792
Substituted oxazine and thiazine oxazolidinone antimicrobials
Filed: 1994-08-16
Issued: 1997-11-18
Expired (Term Ended)
Expires: 2014-08-16
US6514529
Oxazolidinone tablet formulation
Filed: 2001-03-15
Issued: 2003-02-04
Expired (Term Ended)
Expires: 2021-03-15
US6559305
Linezolid—crystal form II
Filed: 2002-05-23
Issued: 2003-05-06
Expired (Term Ended)
Expires: 2022-05-23

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

39

Dispositive

20

Granted

2

Denied

0

Pending / Review

37

Motions by Category

Procedural / Extension Motion 17 Motion for Summary Judgment (Rule 56) 15 Claim Construction / Markman Filing 2 Motion for Summary Judgment (Infringement) 5

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
MOTION by Defendants Apotex, Corp., Apotex, Inc. Apotex's Unopposed Motion for Leave to File an Unredacted Version of its Reply Memoranda of Law in Support of i...
Entry #92 • 2013-12-16 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
RESPONSE by Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLCin Opposition to SEALED MOTION by Defendants Apotex, Corp., Apotex, Inc., Counter Claim...
Entry #86 • 2013-11-06 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
RESPONSE by Plaintiffs Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLC to Sealed motion, 67 [Plaintiffs' Response to Apotex's Local Rule 56.1(a)(3...
Entry #87 • 2013-11-06 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
DECLARATION regarding response in opposition to motion, 86 [Declaration of Reid Huefner in Support of Plaintiffs' Opposition to Defendants' Motion for Summary J...
Entry #88 • 2013-11-06 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
SEALED RESPONSE by Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLC to SEALED MOTION by Defendants Apotex, Corp., Apotex, Inc., Counter Claimants A...
Entry #83 • 2013-11-05 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
SEALED RESPONSE by Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLC to SEALED MOTION by Defendants Apotex, Corp., Apotex, Inc., Counter Claimants A...
Entry #84 • 2013-11-05 Document →

Docket Entries

(99 total)
Pleading / Complaint

COMPLAINT filed by Pharmacia & Upjohn Company LLC, Pfizer Asia-Pacific Pte. Ltd.; Filing fee $ 350, receipt number 0752-8147030. (Attachments: # 1 Exhibit A)(Sernel, Marcus) (Entered: 03/15/2013)

Entry #1 • 2013-03-15
1
Pleading / Complaint

COMPLAINT filed by Pharmacia & Upjohn Company LLC, Pfizer Asia-Pacific Pte. Ltd.; Filing fee $ 350, receipt number 0752-8147030. (Attachments: # 1 Exhibit A)(Sernel, Marcus) (Entered: 03/15/2013)

Entry #1 • 2013-03-15
2

CIVIL Cover Sheet (Sernel, Marcus) (Entered: 03/15/2013)

Entry #2 • 2013-03-15
1

ATTORNEY Appearance for Plaintiffs Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLC by Marcus Edward Sernel (Sernel, Marcus) (Entered: 03/15/2013)

Entry #3 • 2013-03-15
1

ATTORNEY Appearance for Plaintiffs Pfizer Asia-Pacific Pte. Ltd., Pharmacia & Upjohn Company LLC by Reid P. Huefner (Huefner, Reid) (Entered: 03/15/2013)

Entry #4 • 2013-03-15
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc